Regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) synthesis, degradation, and translocation by high-density lipoprotein(2) at a low concentration.
Regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) synthesis, degradation, and translocation by high-density lipoprotein(2) at a low concentration.
复制标题
低浓度高密度脂蛋白 (2) 对酰基辅酶 A:胆固醇酰基转移酶 (ACAT) 合成、降解和易位的调节。
DOI:
10.1161/01.atv.20.12.2636
复制
发表时间:
2000
期刊:
影响因子:
--
通讯作者:
Pownall,HJ
中科院分区:
文献类型:
--
作者:
Li,L;Pownall,HJ
—Although plasma HDL2cholesterol concentration stands in inverse relation to risk for atherosclerotic disease, little is known about the mechanism of the apparent cardioprotection. In mouse P388D1 macrophages, HDL2at a low concentration (≤40 μg/mL) inhibits macrophage acyl-coenzyme A:cholesterol acyltransferase (ACAT), the enzyme that catalyzes esterification of intracellular cholesterol. The effects of HDL2on ACAT synthesis, degradation, and intracellular translocation were investigated in mouse P388D1 macrophages. HDL2at a low concentration enhanced ACAT synthesis but not total ACAT mass. Immunocytochemical studies showed that in the absence of lipoproteins, ACAT associated primarily with the perinuclear region of the cell. The addition of HDL2, however, induced the transfer of ACAT to vesicular structures and the cell periphery adjacent to the plasma membrane. Subfractionation combined with immunoprecipitation complemented these observations and showed that HDL2promoted the transfer of ACAT to the plasma membrane fraction. Brefeldin A, which inhibits vesicular protein transport from the endoplasmic reticulum to the Golgi compartment in mammalian cells, blocked ACAT translocation and partially restored ACAT activity. These results suggest that HDL2is an initiating factor in a signal transduction pathway that leads to intracellular ACAT translocation and inactivation.